Join Exoma CommunityJoin

Your first week with GLP-1: Get to know the changes

Discover what to expect during your first week with a GLP-1 agonist (Tirzepatide/Retatrutide). We explain the changes in appetite, energy and how to manage possible nausea so that your experience is smoother. Get informed to start with confidence!

Your first week with GLP-1: Get to know the changes

· Publicado el · Actualizado el

Discover what to expect during your first week with a GLP-1 agonist (Tirzepatide/Retatrutide). We explain the changes in appetite, energy and how to manage possible nausea so that your experience is smoother. Get informed to start with confidence!

Hello! Are you about to start your journey with a GLP-1 agonist, such as Tirzepatide or Retatrutide? It is completely normal to feel curious or even a little uncertain about what lies ahead. This guide is for you, so you know what is normal and how to prepare. We invite you to read our complete guide to get started if you want to go deeper into this topic.

What are GLP-1 agonists?

GLP-1 (glucagon-like peptide-1) agonists are medications that mimic the action of a natural hormone in your body. This hormone helps regulate blood sugar and the feeling of satiety, which can influence your appetite.

Changes in your appetite

One of the most notable changes you may feel is a decrease in your appetite. You will notice that you feel full faster and for longer. This is because GLP-1 works by slowing the emptying of your stomach and sending signals to your brain that you have already eaten enough.

Your energy level

Although GLP-1 can influence how your body processes energy, you should not experience a drastic change. Some people report feeling a little more tired at first, while others notice no difference. It is important that you pay attention to how you feel.

Possible nausea: What to do?

Nausea is one of the most common side effects at the start of treatment. Not everyone experiences it, but if it happens to you, there are ways to manage it.

When to seek professional help?

Most side effects are mild and temporary. However, it is important to know when you should contact a healthcare professional.

What is normal and what is not during the first week?

Normal:

Not normal (contact your healthcare professional):

In summary

We hope this information is very useful to you as you begin your journey. Remember that each person is different and your experience may vary slightly. For a complete and more detailed guide, we invite you to visit our getting-started guide. You can also explore related products such as Tirzepatide 10 mg y Retatrutide 10 mg.

See also

Literature on the compounds cited

  • Sobre Tirzepatida: LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept (Coskun, et al. · Molecular Metabolism · 2018) PMID 30473097.
  • Sobre Tirzepatida: Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial (Rosenstock, et al. · The Lancet · 2021) PMID 34186022.
  • Sobre Tirzepatida: Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (Thomas, et al. · Journal of Clinical Endocrinology & Metabolism · 2021) PMID 33236115.